FTSE Heads Higher On Mixed UK Jobs Data and Upbeat Chinese Trade Figures
Fiona Cincotta October 13, 2020 2:55 PM
US indices surged ending close to all time highs as fears over a contested US Presidential election ease and large tech surged. Upbeat Chinese trade data and mixed UK jobs numbers are playing into the mix.
The FTSE is heading higher on the open following a solid performance on Wall Street. US indices surged ending close to all time highs as fears over a contested US Presidential election ease and large tech surged. Upbeat Chinese trade data and mixed UK jobs numbers are playing into the mix.
China remains on road to recovery
Upbeat Chinese trade data in the Asian session is helping investors look past the lack of US Congressional agreement over fiscal stimulus. Chinese exports surged 9.9% rising for a fourth straight month in September, whilst imports jumped 13.2% as economies across the globe reopened. Analysts had expected exports to rise 10% and imports to edge just 0.4% higher. China remains clearly on the rad to recover, as it capitalises on economies reopening across the globe.
UK jobs data provides little clarity
UK jobs data threw out mixed signals. Unemployment ticked higher to 4.5% in the three months to August whilst July’s reading was upwardly revised to 4.3%. However, the timelier claimant count increased by a significantly less than forecast 28K vs 78.8K expected. The claimant count is very surprising. We would have expected this to start to show those coming off the furlough scheme as company contribution increases. The broad expectation is still that the UK will see a sharp increase in the number of people unemployed by the end of the year, particularly as the chancellors Job Support Scheme is significantly less generous than the Jobs retention scheme and given that large parts of the UK are likely to see tighter lockdown restrictions in the coming weeks.
Johnson & Johnson halts vaccine trial
News that Johnson & Johnson have paused its covid trial due to an unexplained illness in a participant is keeping risk sentiment in check. An independent safety monitoring board will review and evaluate the data. These pauses are considered normal in large scale vaccine trials. It would have to be a serious event to halt trials, hopes are that this will blow over quickly as it did with AstraZeneca. Johnson & Johnson, which is due to report later today, has been a front runner in the development of a vaccine candidate to fight covid. Given that a vaccine is the surest way to return to pre-covid levels of growth, the markets are particularly sensitive to vaccine developments and news.
A win for Biden is a win for stimulus?
With Joe Biden now 10 points ahead in the polls uncertainty surrounding the election has waned and expected volatility in the equity markets for November and December has fallen significantly. Markets hate uncertainty, anything that can remove a layer of uncertainty is considered risk positive.
The risk on trade continues into Europe, although with less umph, riskier stocks are in demand. Investors are optimistic that a large US fiscal stimulus package is on its way after the election. A win by Joe Biden is expected to be particularly lucrative, Democrats have shown that they support a large scale covid relief package. Markets have made their peace with the idea that stimulus might not be before the elections, but it will be worth waiting for.
This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.
GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.
In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.
GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.
Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit cityindex.com.sg for the complete Risk Disclosure Statement.
Cryptocurrencies are not legal tender currency and trading of derivatives on Cryptocurrencies are currently not covered under any regulatory regime in Singapore. Consequently, investors should be aware they do not have protection under the Securities and Futures Act (Cap. 289). Please ensure that you are fully aware of the risks.